These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 20399539)

  • 21. Effective quality factors for neutrons based on the revised ICRP/ICRU recommendations.
    Veinot KG; Hertel NE
    Radiat Prot Dosimetry; 2005; 115(1-4):536-41. PubMed ID: 16381781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New ICRP recommendations.
    Wrixon AD
    J Radiol Prot; 2008 Jun; 28(2):161-8. PubMed ID: 18495983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Required dose of imaging systems--nuclear medicine].
    Moser E; Schober O
    Radiologe; 1994 Apr; 34(4):202-11. PubMed ID: 8052714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minimizing and communicating radiation risk in pediatric nuclear medicine.
    Fahey FH; Treves ST; Adelstein SJ
    J Nucl Med; 2011 Aug; 52(8):1240-51. PubMed ID: 21764783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Basic anatomical and physiological data for use in radiological protection: reference values. A report of age- and gender-related differences in the anatomical and physiological characteristics of reference individuals. ICRP Publication 89.
    Ann ICRP; 2002; 32(3-4):5-265. PubMed ID: 14506981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effective dose: practice, purpose and pitfalls for nuclear medicine.
    Martin CJ
    J Radiol Prot; 2011 Jun; 31(2):205-19. PubMed ID: 21617297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intercomparison of activity measurements for beta-emitters in Swiss nuclear medicine laboratories.
    Wastiel C; Valley JF; Delaloye AB; Leresche M; Linder R; Sassowsky M; Bochud FO
    J Nucl Med Technol; 2005 Dec; 33(4):238-42. PubMed ID: 16322126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effective dose equivalent from intraoral radiography.
    Stenström B; Henrikson CO; Karlsson L; Sarby B
    Swed Dent J; 1987; 11(1-2):71-7. PubMed ID: 3473713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimated collective effective dose to the population from X-ray and nuclear medicine examinations in Finland.
    Bly R; Järvinen H; Korpela MH; Tenkanen-Rautakoski P; Mäkinen A
    Radiat Prot Dosimetry; 2011 Sep; 147(1-2):233-6. PubMed ID: 21816721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of the new nuclear decay data of ICRP publication 107 on inhalation dose coefficients for workers.
    Manabe K; Endo A; Eckerman KF
    Radiat Prot Dosimetry; 2010 Mar; 138(3):245-50. PubMed ID: 19914964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone marrow dosimetry using blood-based models for radiolabeled antibody therapy: a multiinstitutional comparison.
    Wessels BW; Bolch WE; Bouchet LG; Breitz HB; Denardo GL; Meredith RF; Stabin MG; Sgouros G;
    J Nucl Med; 2004 Oct; 45(10):1725-33. PubMed ID: 15471841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The ICRP protection quantities, equivalent and effective dose: their basis and application.
    Harrison JD; Streffer C
    Radiat Prot Dosimetry; 2007; 127(1-4):12-8. PubMed ID: 18003712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluence-to-dose conversion coefficients for neutrons and protons calculated using the PHITS code and ICRP/ICRU adult reference computational phantoms.
    Sato T; Endo A; Zankl M; Petoussi-Henss N; Niita K
    Phys Med Biol; 2009 Apr; 54(7):1997-2014. PubMed ID: 19265210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effective and organ doses from thoron decay products at different ages.
    Kendall GM; Phipps AW
    J Radiol Prot; 2007 Dec; 27(4):427-35. PubMed ID: 18268373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in radiation exposure from clinical nuclear medicine procedures in Shanghai, China.
    Yi Y; Zheng J; Zhuo W; Gao L
    Nucl Med Commun; 2012 Mar; 33(3):331-6. PubMed ID: 22186909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effective doses in nuclear medicine diagnostic procedures in Greece].
    El-Mantani Ordoulidis S; Siabanopoulou M
    Hell J Nucl Med; 2009; 12(3):304-6. PubMed ID: 19936353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluence-to-dose conversion coefficients for heavy ions calculated using the PHITS code and the ICRP/ICRU adult reference computational phantoms.
    Sato T; Endo A; Niita K
    Phys Med Biol; 2010 Apr; 55(8):2235-46. PubMed ID: 20354281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Basic concepts on protection in nuclear medicine].
    Nogueira A
    Rev Port Cardiol; 1994 May; 13 Suppl 3():13-20. PubMed ID: 8060652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac catheterization: impact of face and neck shielding on new estimates of effective dose.
    von Boetticher H; Lachmund J; Hoffmann W
    Health Phys; 2009 Dec; 97(6):622-7. PubMed ID: 19901597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minimizing and communicating radiation risk in pediatric nuclear medicine.
    Fahey FH; Treves ST; Adelstein SJ
    J Nucl Med Technol; 2012 Mar; 40(1):13-24. PubMed ID: 22393223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.